Group-based Metacognitive Therapy for PTSD in routine psychiatric care.
Official title: A Feasibility Study of Group-Based Metacognitive Therapy (MCT) for Post-Traumatic Stress Disorder (PTSD) in a Routine Healthcare Setting
Run by Karolinska Institutet · NCT07302334 · Data updated 2026-11-12
This project will try group-based Metacognitive Therapy (MCT) for adults with PTSD to see if people accept the treatment and whether symptoms and quality of life improve when it is offered in routine psychiatric care in Sweden.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | November 28, 2025 |
| Main results expected | August 28, 2026 |
| Study ends | November 28, 2026 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT07302334 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a clinical diagnosis of PTSD, a self-rated PCL-5 total score over 30, stable psychotropic medication for at least 4 weeks, fluent in Swedish, and not currently receiving evidence-based trauma-focused therapy are ideal candidates.
✕Probably not a fit
Patients with severe psychiatric comorbidities requiring immediate attention (such as active suicidal ideation, psychosis, or bipolar disorder), those facing an ongoing trauma-related threat, or those already in trauma-focused therapy are unlikely to benefit from or be eligible for this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants will attend 14 weekly group MCT sessions delivered at a specialized psychiatric clinic in Stockholm with broadly inclusive recruitment and minimal exclusion criteria. Primary outcomes focus on feasibility and acceptability, including recruitment and retention rates, data completeness, treatment adherence, and qualitative feedback from participants. Secondary outcomes will measure preliminary changes in PTSD, complex PTSD, depressive symptoms, and quality of life, and will compare dropout rates to those reported for exposure-based PTSD treatments. Outcomes will be measured from pre-treatment to post-treatment and at a 6-month follow-up.
Why it matters
Potential benefit: If successful, group MCT could provide an acceptable, more scalable treatment option that reduces PTSD and depressive symptoms and improves functioning and quality of life for patients in routine care.
How similar studies have gone: Metacognitive Therapy has shown promising results for anxiety, depression, and some individual PTSD studies, but group-based MCT for PTSD delivered within routine psychiatric settings is relatively novel with limited prior data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Fulfills the diagnostic criteria for PTSD based on clinical records * Self-rated total sum score over 30 on the PCL-5 * Age ≥18 years. * Stable psychotropic medication regimen for ≥4 weeks. * Fluent in Swedish. Exclusion Criteria: * Severe psychiatric comorbidities (e.g., suicidal ideation, active psychosis, bipolar disorder) warranting immediate attention. * Current trauma-related threat (e.g., ongoing domestic violence). * Ongoing evidence-based trauma-focused psychological treatment
Where it's running
-
Affektiva, ångest och traumaprogrammet, Psykiatri Sydväst
Stockholm, Sweden Recruiting
Study contacts
- Study coordinator: Maria Bragesjö
- Email: maria.bragesjo@ki.se
- Phone: +46703399387
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS
This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.
-
Internet-delivered ACT for youth with PTSD and chronic pain
A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Floatation-REST for frontline workers with post-traumatic stress symptoms
This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.
-
Short-Term Intensive PTSD Treatment for Military Personnel
This trial tests whether a brief, massed form of CPT and EMDR can quickly reduce PTSD symptoms and related cognitive problems in active-duty military personnel.
-
Exposure by Assessment: Testing AMQ-based EMA on Intrusive Trauma Memories in PTSD
We’re testing whether daily prompts to focus on a traumatic memory (vs. a neutral memory) using a simple at-home EMA can reduce intrusive PTSD memories and overall PTSD symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.